|
Metastatic Lung Cancer Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 73 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Metastatic Lung Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Lung Cancer clinical trial scenario. This report prov.....
Introduction GlobalData's clinical trial report, “Metastatic Lung Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Lung Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Lung Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Metastatic Lung Cancer 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials by Country 8 Top Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Clinical Trials by BRIC Nations 13 Clinical Trials by G7 Nations 14 Clinical Trials in G7 Nations by Trial Status 15 Clinical Trials by E7 Nations 16 Clinical Trials in E7 Nations by Trial Status 17 Clinical Trials by Phase 18 In Progress Trials by Phase 19 Clinical Trials by Trial Status 20 Unaccomplished Trials of Metastatic Lung Cancer 21 Subjects Recruited Over a Period of Time 22 Prominent Sponsors 23 Top Companies Participating in Metastatic Lung Cancer Therapeutics Clinical Trials 25 Prominent Drug Comparison 26 Clinical Trial Profiles 27 Clinical Trial Overview of Top Companies 27 Pfizer Inc. 27 Clinical Trial Overview of Pfizer Inc. 27 Novartis AG 28 Clinical Trial Overview of Novartis AG 28 Clinical Trial Overview of Top Universities / Institutes / Hospitals 29 The University of Texas M. D. Anderson Cancer Center 29 Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 29 Barbara Ann Karmanos Cancer Institute 30 Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 30 H. Lee Moffitt Cancer Center & Research Institute 31 Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 31 University of California, San Diego 32 Clinical Trial Overview of University of California, San Diego 32 Radboud University 33 Clinical Trial Overview of Radboud University 33 The Cancer Biotherapy Research Group 34 Clinical Trial Overview of The Cancer Biotherapy Research Group 34 Oita University 35 Clinical Trial Overview of Oita University 35 Tokyo Women's Medical University 36 Clinical Trial Overview of Tokyo Women's Medical University 36 Shizuoka Cancer Center 37 Clinical Trial Overview of Shizuoka Cancer Center 37 Mayo Clinic 38 Clinical Trial Overview of Mayo Clinic 38 Institut Gustave Roussy 39 Clinical Trial Overview of Institut Gustave Roussy 39 Erasmus MC 40 Clinical Trial Overview of Erasmus MC 40 Cleveland Clinic Hospital 41 Clinical Trial Overview of Cleveland Clinic Hospital 41 University College London 42 Clinical Trial Overview of University College London 42 Memorial Sloan Kettering Cancer Center 43 Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 43 Fred Hutchinson Cancer Research Center 44 Clinical Trial Overview of Fred Hutchinson Cancer Research Center 44 Virginia Commonwealth University 45 Clinical Trial Overview of Virginia Commonwealth University 45 Wake Forest University 46 Clinical Trial Overview of Wake Forest University 46 The University of Tokyo 47 Clinical Trial Overview of The University of Tokyo 47 The First Affiliated Hospital of Guangzhou Medical College 48 Clinical Trial Overview of The First Affiliated Hospital of Guangzhou Medical College 48 Five Key Clinical Profiles 49 Appendix 70 Abbreviations 70 Definitions 70 Research Methodology 71 Secondary Research 71 About GlobalData 72 Contact Us 72 Disclaimer 72 Source 73 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7 Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 Metastatic Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10 Metastatic Lung Cancer Therapeutics Clinical Trials, Europe, Top Countries, 2012* 11 Metastatic Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 12 Metastatic Lung Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 13 Metastatic Lung Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 14 Metastatic Lung Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15 Metastatic Lung Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 16 Metastatic Lung Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 17 Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 18 Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 19 Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 20 Metastatic Lung Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 21 Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 22 Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 24 Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 25 Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 26 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 27 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 28 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 29 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2012* 30 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012* 31 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2012* 32 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012* 33 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cancer Biotherapy Research Group, 2012* 34 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oita University, 2012* 35 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Women's Medical University, 2012* 36 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Shizuoka Cancer Center, 2012* 37 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 38 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Gustave Roussy, 2012* 39 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2012* 40 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cleveland Clinic Hospital, 2012* 41 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University College London, 2012* 42 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 43 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 44 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Virginia Commonwealth University, 2012* 45 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 46 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2012* 47 Metastatic Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The First Affiliated Hospital of Guangzhou Medical College, 2012* 48 List of Figures Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7 Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 Metastatic Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10 Metastatic Lung Cancer Therapeutics Clinical Trials, Europe, Top Countries (%), 2012* 11 Metastatic Lung Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 14 Metastatic Lung Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15 Metastatic Lung Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 17 Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 18 Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 19 Metastatic Lung Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 20 Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 22 Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 23 Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 25 Metastatic Lung Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 26 GlobalData Methodology 71 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
